CLINICAL TRIALS PROFILE FOR MAGNEVIST
✉ Email this page to a colleague
All Clinical Trials for Magnevist
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00185276 ↗ | Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries | Completed | Bayer | Phase 3 | 2003-03-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the infrarenal aorta and peripheral arteries. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography. |
NCT00309075 ↗ | Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries | Completed | Bayer | Phase 3 | 2003-12-01 | The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the calf and foot arteries. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography. |
NCT00310544 ↗ | Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction | Completed | Bayer | Phase 2 | 2006-03-01 | The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Magnevist
Condition Name
Clinical Trial Locations for Magnevist
Trials by Country
Clinical Trial Progress for Magnevist
Clinical Trial Phase
Clinical Trial Sponsors for Magnevist
Sponsor Name